Form 4/A for NVAX NOVAVAX INC
Accepted 2021-08-20 00:00:00 ET · period of report 2021-06-25 · accession 0001209191-21-052811 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| DA | 2021-08-20 | 2021-06-25 | NVAX | MCMANUS MICHAEL A JR | Dir | M - OptEx | — | +3,450 | 9,401 | +58% | — |
| DA | 2021-08-20 | 2021-06-25 | NVAX | MCMANUS MICHAEL A JR | Dir | M - OptEx | $0.00 | -3,450 | 3,450 | -50% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2021-06-25 | M | A | 3,450 | — | 9,401 | D | — | — | (F1) This amendment to the original Form 4 filed on June 29, 2021 is being filed to correct the number of restricted stock units ("RSUs") vested on June 25, 2021. (F2) Each RSU represents a contingent right to receive one share of Novavax, Inc. (the "Company") common stock. |
| 2 | Derivative | Restricted Stock Units | 2021-06-25 | M | D | 3,450 | $0.00 | 3,450 | D | — · — to — | 3,450 Common Stock | (F1) This amendment to the original Form 4 filed on June 29, 2021 is being filed to correct the number of restricted stock units ("RSUs") vested on June 25, 2021. (F2) Each RSU represents a contingent right to receive one share of Novavax, Inc. (the "Company") common stock. (F3) One hundred percent (100%) of the RSUs subject to this grant under the Company's Amended and Restated 2015 Stock Incentive Plan, as amended, vested on the first anniversary of the June 25, 2020 grant date subject to continued service on the Company's Board of Directors through the vesting date. |